ChinaTalk Why won't China get vaccinated?
Sep 15, 2022
In this engaging discussion, Mary Brazelton, an associate professor at Cambridge University specializing in global studies of science and medicine, dives into the complexities of vaccine hesitancy in China. Co-host Henry Li brings a policy perspective as they analyze historical mistrust from Unit 731 to modern COVID-19 initiatives. The conversation explores the role of Traditional Chinese Medicine, the evolution of public health strategies from SARS, and the pressing need for global coordination in pandemic responses. It’s a fascinating blend of history, culture, and current health dynamics.
AI Snips
Chapters
Books
Transcript
Episode notes
China's Vaccination Vulnerability
- China achieved high initial COVID-19 vaccination rates, but booster rates, especially among the elderly, remain low.
- This poses a vulnerability if China abandons its zero-COVID policy, as seen in Hong Kong's experience with high death rates among unvaccinated elderly.
Vaccine Hesitancy and Prioritization
- China prioritized vaccinating younger, more socially active individuals first during the initial vaccine rollout.
- Vaccine hesitancy and logistical challenges contribute to lower vaccination rates among the elderly.
Changchun Biotech Scandal
- The 2018 Changchun Biotech scandal, where ineffective vaccines were given to children, eroded public trust in vaccine distribution.
- This incident fueled vaccine hesitancy and raised concerns about the safety of vaccines in China.
